Serum from Nipah Virus Patients Recognises Recombinant Viral Proteins Produced in <i>Escherichia coli</i>

DOI Web Site Web Site PubMed 26 References
  • Tiong Vunjia
    Department of Medical Microbiology, Faculty of Medicine, University of Malaya
  • Lam Chui-Wan
    Department of Medical Microbiology, Faculty of Medicine, University of Malaya
  • Phoon Wai-Hong
    Department of Medical Microbiology, Faculty of Medicine, University of Malaya
  • AbuBakar Sazaly
    Department of Medical Microbiology, Faculty of Medicine, University of Malaya Tropical Infectious Diseases Research and Education Centre, University of Malaya
  • Chang Li-Yen
    Department of Medical Microbiology, Faculty of Medicine, University of Malaya Tropical Infectious Diseases Research and Education Centre, University of Malaya

Bibliographic Information

Other Title
  • Serum from Nipah Virus Patients Recognises Recombinant Viral Proteins Produced in Escherichia coli

Search this article

Abstract

The genes for Nipah virus (NiV) proteins were amplified from viral RNA, cloned into the plasmid pTriEx-3 Hygro, expressed, and purified using immobilized metal affinity chromatography. The recombinant N, F, and G NiV proteins (rNiV-N, rNiV-F, and rNiV-G), were successfully expressed in Escherichia coli and purified with a yield of 4, 16, and 4 mg/L, respectively. All 3 recombinant viral proteins reacted with all 19 samples of NiV-positive human sera. The rNiV-N and rNiV-G proteins were the most immunogenic. The recombinant viral proteins did not react with any of the 12 NiV-negative sera. However, serum from a patient with a late-onset relapsing NiV infection complication was found to be primarily reactive to rNiV-G only. Additionally, there is a distinctive variation in the profile of antigen-reactive bands between the sample from a case of relapsing NiV encephalitis and that of acute NiV infection. The overall findings of this study suggest that the recombinant viral proteins have the potential to be developed further for use in the detection of NiV infection, and continuous biosurveillance of NiV infection in resource-limited settings.

Journal

  • Japanese Journal of Infectious Diseases

    Japanese Journal of Infectious Diseases 70 (1), 26-31, 2017

    National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee

References(26)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top